DMD Digital Health Connections Group Inc (APTOF) - Net Assets
Based on the latest financial reports, DMD Digital Health Connections Group Inc (APTOF) has net assets worth $-27.17 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.01 Million) and total liabilities ($37.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DMD Digital Health Connections Group Inc (APTOF) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-27.17 Million |
| % of Total Assets | -271.34% |
| Annual Growth Rate | N/A |
| 5-Year Change | -136.6% |
| 10-Year Change | N/A |
| Growth Volatility | 120.93 |
DMD Digital Health Connections Group Inc - Net Assets Trend (2013–2025)
This chart illustrates how DMD Digital Health Connections Group Inc's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of DMD Digital Health Connections Group Inc to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for DMD Digital Health Connections Group Inc (2013–2025)
The table below shows the annual net assets of DMD Digital Health Connections Group Inc from 2013 to 2025. For live valuation and market cap data, see market cap of DMD Digital Health Connections Group Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-27.17 Million | -498.00% |
| 2024-12-31 | $-4.54 Million | -56.60% |
| 2023-12-31 | $-2.90 Million | -107.69% |
| 2022-12-31 | $37.74 Million | -49.16% |
| 2021-12-31 | $74.24 Million | +244.67% |
| 2017-12-31 | $21.54 Million | +20.27% |
| 2016-12-31 | $17.91 Million | +73.83% |
| 2015-12-31 | $10.30 Million | +760.38% |
| 2014-12-31 | $-1.56 Million | +49.73% |
| 2013-12-31 | $-3.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to DMD Digital Health Connections Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 53348300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $539.27 Million | % |
| Total Equity | $-27.17 Million | 100.00% |
DMD Digital Health Connections Group Inc Competitors by Market Cap
The table below lists competitors of DMD Digital Health Connections Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mortgage Advice
LSE:MAB1
|
$4.01 Million |
|
Mears Group plc
LSE:MER
|
$4.01 Million |
|
Linkage Global Inc Ordinary Shares
NASDAQ:LGCB
|
$4.01 Million |
|
Entreprendre
PA:ALENR
|
$4.01 Million |
|
Zephyr Minerals Ltd
V:ZFR
|
$4.00 Million |
|
KWG Group Holdings Limited
F:KOU
|
$4.00 Million |
|
Telo Genomics Corp
V:TELO
|
$4.00 Million |
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
$3.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DMD Digital Health Connections Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -4,543,000 to -27,167,000, a change of -22,624,000.
- Net loss of 25,468,000 reduced equity.
- New share issuances of 828,000 increased equity.
- Other factors increased equity by 2,016,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-25.47 Million | -93.75% |
| Share Issuances | $828.00K | +3.05% |
| Other Changes | $2.02 Million | +7.42% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares DMD Digital Health Connections Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $362.26 | $1.58 | x |
| 2022-12-31 | $183.87 | $1.58 | x |
| 2023-12-31 | $-10.96 | $1.58 | x |
| 2024-12-31 | $-2.26 | $1.58 | x |
| 2025-12-31 | $-10.64 | $1.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DMD Digital Health Connections Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-4.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 25.52% | 1.09x | 0.00x | $4.72 Million |
| 2014 | 0.00% | 5.82% | 1.16x | 0.00x | $1.37 Million |
| 2015 | 98.64% | 31.56% | 1.21x | 2.58x | $9.13 Million |
| 2016 | 40.52% | 17.68% | 1.25x | 1.84x | $5.47 Million |
| 2017 | 19.38% | 8.89% | 1.34x | 1.63x | $2.02 Million |
| 2021 | -88.04% | 0.00% | 0.00x | 1.11x | $-72.78 Million |
| 2022 | -110.82% | 0.00% | 0.00x | 1.35x | $-45.60 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-50.92 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-24.98 Million |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-22.75 Million |
Industry Comparison
This section compares DMD Digital Health Connections Group Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $155,285,360
- Average return on equity (ROE) among peers: -101.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DMD Digital Health Connections Group Inc (APTOF) | $-27.17 Million | 0.00% | N/A | $4.01 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-34.80 Million | 0.00% | 0.00x | $83.17 Million |
| Abcellera Biologics Inc (ABCL) | $830.51 Million | 14.32% | 0.21x | $1.61 Billion |
| Abeona Therapeutics Inc (ABEO) | $-26.99 Million | 0.00% | 0.00x | $321.39 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $266.97 Million | -19.62% | 0.16x | $155.29 Million |
| Abpro Holdings, Inc. (ABP) | $3.07 Million | -479.81% | 1.57x | $2.00 Million |
| Absci Corp (ABSI) | $179.13 Million | -57.56% | 0.19x | $1.01 Billion |
| Arbutus Biopharma Corp (ABUS) | $182.50 Million | -46.25% | 0.30x | $831.63 Million |
| ABVC Biopharma Inc (ABVC) | $4.59 Million | -357.76% | 1.38x | $35.10 Million |
| Abivax SA American Depositary Shares (ABVX) | $33.94 Million | -14.97% | 0.12x | $7.98 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $113.93 Million | -49.49% | 0.18x | $3.66 Billion |
About DMD Digital Health Connections Group Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloi… Read more